URGN
UroGen Pharma Ltd
40.70$
-1.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -99.9% | +41,015.8% | +0.0% | -95.8% | +47.1% | -24.3% | -22.3% | +198.6% | -100.0% | – | -100.0% | – | – | – | +830.4% | +130.2% | -6.0% | +74.1% | -12.9% | +42.5% | -16.1% | +22.4% | -3.1% | +12.4% | -5.0% | +23.0% | -1.4% | +12.8% | -20.2% | +16.3% | +15.4% | -2.5% | -17.5% | +19.6% | +13.5% | +37.7% | +34.7% | +42.2% | – | |
| – | -99.5% | -35.7% | +1,538.9% | +0.0% | -2.7% | +49.8% | -26.0% | +231.8% | -29.1% | +2,899.1% | -100.0% | – | -100.0% | – | – | +543.8% | +111.0% | +37.6% | +59.1% | -12.8% | +27.7% | -4.0% | +21.0% | +9.4% | +12.0% | +0.1% | +7.9% | -3.1% | -3.4% | -24.4% | +29.0% | +10.0% | +0.7% | -5.7% | +52.4% | -7.7% | +0.3% | +25.8% | +58.8% | – | |
| – | – | -100.0% | +751,600.0% | +0.0% | -99.5% | +27.5% | -9.8% | -1,778.3% | – | -23,226.8% | – | -130,394.4% | – | – | – | +872.8% | +132.0% | -9.9% | +76.2% | -12.9% | +44.3% | -17.5% | +22.6% | -4.6% | +12.4% | -5.7% | +25.2% | -1.1% | +14.9% | -19.7% | +15.0% | +16.0% | -2.9% | -18.9% | +15.3% | +17.1% | +42.7% | +35.5% | +40.7% | – | |
| – | -17.4% | +12.3% | +37.0% | +54.0% | +20.3% | +12.7% | +8.5% | +15.7% | +19.8% | -15.2% | +2.8% | -5.2% | +111.9% | -17.4% | -51.1% | +26.0% | +21.5% | -15.3% | +15.3% | -1.7% | +9.7% | -3.0% | -0.4% | +3.6% | +10.6% | -13.7% | -7.3% | -11.7% | +10.5% | +37.1% | -0.6% | -26.3% | +31.2% | +33.4% | -4.8% | -25.9% | +2.2% | +9.0% | +11.1% | – | |
| – | -62.0% | -28.8% | +162.9% | -4.4% | +56.3% | +76.6% | +68.2% | +5.3% | +16.8% | +1.2% | +8.4% | +1.4% | +41.3% | +11.3% | +9.3% | -8.1% | +0.4% | +0.0% | +0.6% | -3.0% | +84.7% | -46.7% | -2.2% | -8.5% | +13.4% | +13.1% | -8.1% | -3.3% | +12.9% | +11.2% | +10.1% | -3.7% | +20.4% | +0.3% | +23.5% | -13.0% | +4.7% | +30.8% | -5.9% | – | |
| – | -41.1% | -1.7% | +68.2% | +31.4% | +30.4% | +34.3% | +35.0% | +9.9% | +18.2% | -6.6% | +6.0% | -1.3% | +69.9% | -3.2% | -16.7% | +0.5% | +7.1% | -5.4% | +5.3% | -2.6% | +2.8% | -1.5% | -1.5% | -3.9% | +12.3% | +2.4% | -7.8% | -6.1% | +12.1% | +19.4% | +6.2% | -11.4% | +23.5% | +10.2% | +13.3% | -16.9% | +4.0% | +25.0% | -2.0% | – | |
| – | – | -125.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -47.9% | -93.5% | +290.6% | +123.2% | +0.5% | -88.5% | +93.8% | +0.0% | +0.0% | -83.1% | +5,976.2% | – | – | -99.0% | – | – | – | – | – | +113.9% | +8.7% | -96.2% | +694.0% | +20.3% | +19.6% | +10.2% | +5.9% | +1.4% | -6.0% | -31.8% | +41.4% | -21.4% | +43.0% | +4.5% | +115.7% | -8.9% | +62.7% | -33.2% | -43.8% | – | |
| – | – | -126.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | +0.0% | -1,457.9% | – | – | – | -296.0% | – | – | – | – | – | – | – | +0.0% | -90.8% | +2,070.2% | -83.2% | -71.4% | -90.2% | +2,115.6% | -90.3% | -69.6% | +157.1% | -116.7% | – | -98.6% | -29.6% | +139.5% | +2,811.0% | -85.2% | +158.9% | -203.8% | – | – | – | – | |
| – | – | -127.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -125.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.